Author(s):
Kajal Pansare, Ganesh Sonawane, Chandrashekhar Patil, Sunil Mahajan, Deepak Sonawane, Ritu Gilhotra, Shweta Sharma
Email(s):
kajalgsonawane@gmail.com
DOI:
10.52711/0975-4385.2026.00013
Address:
Kajal Pansare1*, Ganesh Sonawane1, Chandrashekhar Patil1, Sunil Mahajan1, Deepak Sonawane1, Ritu Gilhotra2, Shweta Sharma3
1Divine College of Pharmacy, Satana, Dist. Nashik, Maharashtra, India.
2Gyan Vihar School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India.
3IIMT College of Pharmacy, Greater Noida, Uttar Pradesh, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 1,
Year - 2026
ABSTRACT:
Amaryllis belladonna, commonly known as Belladonna Lily or Naked Ladies, is a medicinally significant plant recognized for its rich phytochemical composition, particularly alkaloids such as lycorine and galantamine. These bioactive compounds exhibit diverse pharmacological activities, including anticancer, antimicrobial, anti-inflammatory, neuroprotective, and antioxidant properties. Despite its promising therapeutic potential, the plant contains toxic alkaloids, necessitating caution in its medicinal use. This review comprehensively explores the phytochemical profile, pharmacological activities, toxicological concerns, and ethnobotanical significance of Amaryllis belladonna. It also highlights the challenges of translating preclinical findings into clinical applications, emphasizing the need for further interdisciplinary research, clinical trials, and sustainable conservation strategies. The review aims to provide a foundation for future studies and the potential development of standardized therapeutic formulations derived from this plant.
Cite this article:
Kajal Pansare, Ganesh Sonawane, Chandrashekhar Patil, Sunil Mahajan, Deepak Sonawane, Ritu Gilhotra, Shweta Sharma. Phytochemical Profile and Therapeutic Potential of Amaryllis belladonna. Research Journal of Pharmacognosy and Phytochemistry. 2026; 18(1):88-5. doi: 10.52711/0975-4385.2026.00013
Cite(Electronic):
Kajal Pansare, Ganesh Sonawane, Chandrashekhar Patil, Sunil Mahajan, Deepak Sonawane, Ritu Gilhotra, Shweta Sharma. Phytochemical Profile and Therapeutic Potential of Amaryllis belladonna. Research Journal of Pharmacognosy and Phytochemistry. 2026; 18(1):88-5. doi: 10.52711/0975-4385.2026.00013 Available on: https://www.rjpponline.org/AbstractView.aspx?PID=2026-18-1-13
9. REFERENCES:
1. Stearn WT. The Amaryllis Family: A Taxonomic Revision. London: Royal Botanic Gardens; 1998.
2. Snijman DA. A Revision of the Genus Amaryllis. Botany Journal of South Africa. 2002;37(4):315-26.
3. Anderson JG. Horticultural Aspects of Amaryllis belladonna. Horticultural Review. 2015;42(3):127-35.
4. Van Wyk BE, Gericke N. People's Plants: A Guide to Useful Plants of Southern Africa. Pretoria: Briza Publications; 2000.
5. Bastida J, Berkov S, Torras-Claveria L, Codina C. The Alkaloids of the Amaryllidaceae Family. Phytochemistry Reviews. 2006;5(1):1-19.
6. Heinrich M, Teoh HL. Galanthamine from snowdrop—the development of a modern drug against Alzheimer's disease from local Caucasian knowledge. J Ethnopharmacol. 2004;92(2-3):147-62.
7. Elgorashi EE, Van Staden J. Pharmacological Properties of Amaryllidaceae Alkaloids: A Review. Planta Med. 2004;70(10):847-52.
8. Meerow AW, Snijman DA. Phylogeny of the Amaryllidaceae: Molecules and Morphology. Annals of Botany. 1998;81(5):527-37.
9. Duncan G. The Amaryllis Family: A Comprehensive Guide. Cape Town: National Botanical Institute; 2002.
10. Snijman DA. A Systematic Revision of Amaryllis belladonna. Botanical Journal of South Africa. 2004;40(1):45-56.
11. Manning JC, Goldblatt P, Snijman DA. The Color Encyclopedia of Cape Bulbs. Portland: Timber Press; 2002.
12. Wiese MV. Storage and Dormancy in Geophytes: A Study of Amaryllis belladonna. Plant Physiology. 2001;37(3):225-34.
13. Taylor NJ. Root Morphology and Function in Bulbous Plants. Horticultural Science. 2003;38(6):982-7.
14. Van Jaarsveld E. The Cape Bulbs: Ecology and Cultivation. Pretoria: Briza Publications; 2006.
15. Mathew B. The Smaller Bulbs. London: B.T. Batsford; 1987.
16. Cowling RM, Pierce SM. Plant Ecology of the Cape Floristic Region. Annual Review of Ecology and Systematics. 2001;32(1):307-32.
17. Van Wyk BE, Gericke N. People's Plants: A Guide to Useful Plants of Southern Africa. Pretoria: Briza Publications; 2000.
18. Snijman DA. A Systematic Revision of Amaryllis belladonna. Botanical Journal of South Africa. 2004;40(1):45-56.
19. Taylor JL, Rabe T, McGaw LJ, Jäger AK, Van Staden J. Towards the Scientific Validation of Traditional Medicinal Plants. Plant Growth Regulation. 2001;34(1):23-37.
20. Cowling RM, Pierce SM. Plant Ecology of the Cape Floristic Region. Annual Review of Ecology and Systematics. 2001;32(1):307-32.
21. Elgorashi EE, Van Staden J. Pharmacological Properties of Amaryllidaceae Alkaloids: A Review. Planta Med. 2004;70(10):847-52.
22. Yadav R, Khare RK, Singhal A. Antioxidant and Anti-inflammatory Activities of Flavonoids in Medicinal Plants. Journal of Drug Research. 2017;4(5):110-22.
23. Cowan MM. Plant Products as Antimicrobial Agents. Clinical Microbiology Reviews. 1999;12(4):564-82.
24. Nahar L, Zahan R, Sarker SD. Phytochemical Profiling Using HPLC Techniques. Journal of Chromatographic Science. 2021;59(4):267-76.
25. Elgorashi EE, Van Staden J. Pharmacological Properties of Amaryllidaceae Alkaloids: A Review. Planta Med. 2004;70(10):847-52.
26. Heinrich M, Lee Teoh H. Galanthamine from Snowdrop—the Development of a Modern Drug against Alzheimer’s Disease from Local Caucasian Knowledge. J Ethnopharmacol. 2004;92(2-3):147-62.
27. Wang B, Yuan P, Li Z, et al. Antitumor Properties of Haemanthamine. Chinese Journal of Natural Medicines. 2019;17(6):449-57.
28. Oleszek W, Hamed AI. Saponins in Food and Medicinal Plants. Natural Product Communications. 2010;5(1):1785-97.
29. Yadav R, Khare RK, Singhal A. Anti-inflammatory and Antioxidant Activities of Flavonoids. J Drug Res. 2017;4(5):110-22.
30. Shellie R, Marriott P, Morrison P. Comprehensive GC-MS for Volatile Compound Analysis. J Chromatogr A. 2001;936(1-2):143-56.
31. Basha S, Pradeepkumar G, Sudarsan R, et al. LC-MS Analysis for Phytochemical Profiling. Analytical Chem Res. 2016;9(1):49-56.
32. Wang H, Zhang L, Wang Q, et al. Lycorine as an Antimalarial Agent. Chinese Journal of Infectious Diseases. 2017;13(2):52-6.
33. Elgorashi EE, Van Staden J. Hepatoprotective Properties of Amaryllidaceae Alkaloids. Planta Med. 2012;78(10):843-52.
34. Díaz-González J, Sánchez-Moreno C, Vázquez-Álvarez Y, et al. Toxic Effects of Lycorine on Human Hepatocellular Carcinoma Cells. J Nat Toxins. 2018;27(5):439-47.
35. Zaidan A, Talib R, Ibrahim R. Poisoning from Amaryllis belladonna in Children: Report of Two Fatal Cases. J Clin Toxicol. 2017;45(6):479-83.
36. González R, Sabater C, Luque J. Toxicity Assessment of Amaryllis belladonna Extracts in Rodents. J Appl Toxicol. 2003;23(2):89-93.
37. González A, Martínez O, Mena D, et al. The Hepatotoxic Effects of Lycorine in Rodent Models. Toxicol Lett. 2011;205(2):118-26.
38. Zhang L, Wei H, Li Z, et al. Standardization of Galantamine in Amaryllis belladonna Extracts for Medicinal Use. J Pharm Biomed Anal. 2013;55(5):755-60.
39. Quijano J, Zora M, Ortiz R. Risk of Toxicity in the Therapeutic Use of Amaryllis belladonna. J Pharm Res. 2015;12(4):225-33.
40. Sato Y, Iizuka Y, Hirano S. Lycorine Toxicity in Pregnancy and Breastfeeding: A Review of Literature. Obstet Med. 2016;24(1):39-45.
41. Fadaei R, Yazdanparast R. Safe Use of Herbal Medicines in Traditional Practices. Herbal Med Journal. 2018;11(2):95-102.
42. Rajesh R, Karthik S, Gupta S. Standardization of Amaryllis belladonna extracts: Approaches and challenges. J Pharm Biomed Anal. 2021; 186:113312.
43. Sharma S, Reddy P, Loke L. Variability of alkaloid content in Amaryllis belladonna across different geographical regions. Phytochemicals. 2022;35(4):563-570.
44. Sun L, Zhang W, Ye X. Tissue culture and biotechnology for sustainable cultivation of Amaryllis belladonna. Biotechnol Adv. 2017;35(3):235-242.
45. Choudhury D, Singh H, Rao S. Sustainable farming practices for medicinal plants: A case study on Amaryllis belladonna. Environ Impact Assess Rev. 2020; 80:106329.